CD8A and neoplasm: We observed that NAC treatment increased the percentage of tumor-infiltrating wild-type CD45.2+ Foxp3– T cells, enhanced the expression of IFN-γ in tumor-infiltrating wild-type Treg cells and promoted the tumor infiltration of CD8+ effector T cells (Fig. 7j–m).